Global Liver Institute Launches Final Nonalcoholic Steatohepatitis (NASH) Externally-Led Patient-Focused Drug Development Meeting Outcome Report (Washington, DC, Wednesday, March 9,...
Partnership Applications Now Open Washington, DC – March 7, 2022 – Global Liver Institute (GLI) will convene the fifth International NASH Day (#NASHday) on June 9, 2022 with the theme Stop NASH...
GLI’s Liver Action Network Supports World Obesity Day to Acknowledge Strong Connection Between NASH and Obesity As members of Global Liver Institute’s Liver Action Network (LAN), the undersigned...
(Washington, D.C., March 2, 2022) – Global Liver Institute (GLI) proudly announces the expansion of the Liver Action Network (LAN) to include a partnership with Empire Liver...
(Washington, DC, Wednesday, February 16, 2022)—Today, Global Liver Institute (GLI) applauds the confirmation of the new Food and Drug Administration (FDA) Commissioner Dr. Robert Califf. On Tuesday,...
Transforming the Public Consciousness with Conversations for and about the Rare Liver Disease Community WASHINGTON, DC, FEBRUARY 1, 2022 – Global Liver Institute (GLI), a patient-led...
POLICY PERSPECTIVE Rapid advancements to policy and committees welcomed in the new year. One of the most highlighted actions was the advancement of the nomination of Dr. Robert Califf as the...
Fatty liver disease (FLD) and nonalcoholic steatohepatitis (NASH) are increasing in prevalence worldwide, creating a major global public health crisis. To adequately educate patients, practitioners,...
As we enter a third calendar year marked by COVID-19, the Omicron variant has caused pandemic peaks in cases and hospitalizations. However, we also have a greater understanding of the disease–and...
Washington, DC, January 14, 2022 – In 2021, the Global Liver Institute (GLI) formed the Liver Action Network (LAN) to better synchronize engagement across the liver advocacy...
Recent News
GLI Supports the Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., June 9, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act, which was recently introduced by Senators Bill Cassidy (R-LA)...
Hep C Elimination Bill - Statement of Support Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to implement a nationwide elimination program for the hepatitis C virus...
Liver Health Insights, Events, and a Global ChallengeA Note from the Director, Dr. Sharon H. Jaycox Reflecting on EASL Congress 2025 – A Call to Action for Liver Health Equity Attending EASL 2025 in Amsterdam was an eye-opening and inspiring experience. I had the...
Addressing Liver Cancer Disparities & Advancing TreatmentGlobal Liver Institute brings you key updates in liver cancer care and health equity. This edition features a 5-year update on the Financial Toxicity Tumor Board Model, highlighting how multidisciplinary...
First Ever Rare Liver Disease Patient Cured with Personalized Gene Therapy Treatment Collaboration and Ideas Driven from Conversations at EASL Congress, Amsterdam Kristin Hatcher, Director of our Pediatric and Rare Liver Diseases Program, joined global...
